Valence Life Sciences
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio0 active
3Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
41Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Entrada Therapeutics | Biotech | Public | Apr 13, 2021 | $150.9M |
| Praxis Precision Medicine | Biotech | Public | — | — |
Peer ranks
Portfolio size#136
Portfolio exits#69
Raises, 12 months#88
Co-investors#44
Co-investors
- Deerfield Capital ManagementVenture capital2 shared
- Omega FundsVenture capital2 shared
- Perceptive AdvisorsVenture capital2 shared
- RA CapitalVenture capital2 shared
- RTW InvestmentsVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- XontogenyVenture capital2 shared
- 5AM VenturesVenture capital1 shared
- Alexandria Venture InvestmentsVenture capital1 shared
- Apple Tree PartnersVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.